Acupuncture and moxibustion for early Parkinson's motor symptoms
Part of Bones, joints & muscles, Brain & nervous system clinical trials.
This trial tests whether acupuncture and moxibustion can help improve movement symptoms in people with early to moderate Parkinson's disease. It is designed to see if adding these treatments to your regular care offers extra benefits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 30 and 80 years old.
- You must have been diagnosed with Parkinson's disease at an early to moderate stage (Hoehn-Yahr stage less than 3).
- You cannot have had deep brain stimulation (DBS) surgery.
- You should not have any severe medical conditions like heart, lung, liver, kidney, or blood clotting problems.
- You must not have received acupuncture or moxibustion in the past 3 months.
- You cannot be pregnant or breastfeeding, or have a history of allergic reaction to acupuncture or moxibustion.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new oral medication for people with early-onset Parkinson's disease. It aims to see if the drug safely improves motor symptoms and quality of life compared to a placebo.
This trial tests whether a gentle electrical stimulation on the forehead (trigeminal nerve) can improve movement problems in people with Parkinson's disease. It is designed for people who are already on stable Parkinson's medication.
This trial tests a non-invasive brain stimulation technique (using electrical currents applied through the scalp) aimed at the subthalamic nucleus—a brain region involved in movement control—to help reduce both movement-related symptoms (like tremor and stiffness) and non-movement symptoms (like mood and sleep problems) in people with Parkinson's disease.
This trial tests a new tablet (VG081821AC) for people with early-to-mid-stage Parkinson's disease who have not recently used levodopa. The goal is to see if it can improve movement symptoms safely.
This early-stage trial tests a new medication called Lu AF28996 in Chinese patients with Parkinson's disease who experience predictable on-off episodes (times when medication works well versus poorly). The study aims to see if this drug can help reduce those difficult off periods.
This trial tests whether acupuncture can help people with Parkinson's disease who also have chronic appendicitis. It aims to see if treating the appendix inflammation may also improve Parkinson's symptoms.
Hear when a new Parkinson's Disease (PD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.